The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. 89bio Inc shares valued at $91,171 were purchased by QUOC LE-NGUYEN on Apr 15 ’25. At $5.95 per share, QUOC LE-NGUYEN acquired 15,329 shares.
Also, RA CAPITAL MANAGEMENT, L.P. purchased 5,714,285 shares, netting a total of over 49,999,994 in proceeds. Following the buying of shares at $8.75 each, the insider now holds 19,554,319 shares.
Before that, McWherter Charles had added 10,000 shares to its account. In a trade valued at $67,100, the Director bought 89bio Inc shares for $6.71 each. Upon closing the transaction, the insider’s holdings increased to 10,000 shares, worth approximately $0.15 million.
As published in their initiating research note from Goldman on March 14, 2025, 89bio Inc [ETNB] has been a Neutral and the price target has been revised to $11. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in mid March. As of February 04, 2025, Wolfe Research has initiated its “an Outperform” rating for ETNB.
Analyzing ETNB Stock Performance
During the last five days, there has been a surge of approximately 6.32%. Over the course of the year, 89bio Inc shares have dropped approximately -24.68%. Shares of the company reached a 52-week high of $11.84 on 02/05/25 and a 52-week low of $4.16 on 04/09/25. A 50-day SMA is recorded $8.52, while a 200-day SMA reached $8.30.
Support And Resistance Levels for 89bio Inc (ETNB)
According to the 24-hour chart, there is a support level at 5.69, which, if violated, would cause prices to drop to 5.49. In the upper region, resistance lies at 6.08. The next price resistance is at 6.27. RSI (Relative Strength Index) is 40.92 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.20, which suggests the price will decrease in the coming days. Percent R is at 63.81%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.